JP Morgan Chase’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
IC
YCM
EAM
VA
BFM
JP Morgan Chase's PASG Position: Q2 2026 in Review
JP Morgan Chase held its Passage Bio (PASG) position steady in Q2 2026 at 15 shares worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #7559.
JP Morgan Chase first reported a position in PASG in Q2 2020 and has held it in 25 quarters since. The position peaked at $10.2M in Q2 2021. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- JP Morgan Chase held 15 shares of Passage Bio worth $73 as of Q2 2026.
- JP Morgan Chase left its Passage Bio share count unchanged in Q2 2026.
- Passage Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7559 holding.
- JP Morgan Chase first reported a position in Passage Bio in Q2 2020 and has held it in 25 quarters since.
- JP Morgan Chase's Passage Bio position peaked at $10.2M in Q2 2021.
- 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.